| Procedure n=63 | Discharge n=63 | 6 months n=63 | 12 months n=62 | 36 months n=56 | |
| Thromboembolic events | 2 (3.2%) | 0 (0.0%) | 0 (0.0%) | 2 (3.2%) | |
| Asymptomatic | 1 (1.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| Symptomatic without sequelae | 1 (1.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| Symptomatic with sequelae | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| Intraprocedural rupture | 2 (3.2%) | NA | NA | NA | NA |
| Morbidity† | 0 (0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (1.79%) |
| Mortality | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (1.79%) |
*Occlusion grade obtained from core laboratory data.
†Defined as mRS>2 if baseline ≤2; mRS+1 or more if baseline >2; mRS>2 if ruptured at baseline.